Adicet Bio, Inc. — Director's Dealing 2022

Sep 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-09-14

Reporting Person: Schor Chen (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-14	Common Stock	S	952	$18.00	Disposed	138737	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	122712	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.